Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ImClone | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

ImClone

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Kenneth J. Zuerblis has been named senior vice president and chief financial officer at ImClone Systems. Mr. Zuerblis has more than 25 years of experience in financial and operational management. He previously served as chief financial officer of Enzon Pharmaceuticals, joining that company in 1991 and serving as its CFO from 1994 to 2005.

“Ken brings to ImClone a valuable combination of strategic, financial, operational and public company experience as well as a strong commitment to the development of new treatment options for cancer,” said John H. Johnson, chief executive officer of ImClone. “He has an impressive track record in growing a development-stage organization into a profitable multi-product biopharmaceutical company. We believe Ken will contribute substantially to ImClone’s efforts in becoming a fully-integrated global leader in cancer therapies as we continue to aggressively pursue initiatives to maximize our Erbitux franchise and further advance our robust pipeline of novel antibodies.”

Prior to joining Enzon, Mr. Zuerblis was at KPMG LLP where he held positions of increasing responsibility over a 10-year period, serving in various advisory roles, including strategic business, tax, audit, and debt and equity financings. Mr. Zuerblis is a certified public accountant and has a degree in accounting from Seton Hall University.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters